Estimation of intracardiac shunts in young children with a novel indicator dilution technology

Theodor Skuli Sigurdsson1,2, Lars Lindberg3

  • 1Department of Pediatric Anesthesia and Intensive Care, Children´s Hospital, University Hospital of Lund, Lund, Sweden. theodors@landspitali.is.

Scientific Reports
|January 30, 2020
PubMed

Insights

A new COstatus monitor shows promise for detecting intracardiac shunts in children, accurately identifying their presence but slightly underestimating shunt ratios compared to invasive methods.

Area of Science:

  • Pediatric Cardiology
  • Medical Device Technology
  • Hemodynamics

Background:

  • Accurate assessment of intracardiac shunts is crucial for pediatric cardiac surgery planning.
  • Current methods like echocardiography lack quantitative shunt ratio (Qp/Qs) estimation.
  • Invasive techniques for Qp/Qs measurement carry inherent risks.

Purpose of the Study:

  • To validate the COstatus monitor, a novel device using indicator dilution technology, for estimating intracardiac shunt ratios (Qp/Qs) in children.
  • To compare the COstatus monitor's performance against established invasive reference techniques.
  • To assess the device's utility before and after corrective cardiac surgery.

Main Methods:

  • Prospective, observational, method-comparison study at a single center.
  • COstatus monitor (indicator dilution) compared with perivascular ultrasonic flow probes and the oximetric shunt equation.
  • Inclusion of pediatric patients undergoing corrective cardiac surgery.

Main Results:

  • The COstatus monitor demonstrated high sensitivity and specificity in detecting intracardiac shunts.
  • A trend towards underestimation of shunt ratios (Qp/Qs) was observed compared to reference methods.
  • The device provided quantitative estimates of pulmonary to systemic blood flow ratios.

Conclusions:

  • The COstatus monitor is a potentially valuable non-invasive tool for evaluating intracardiac shunts in pediatric patients.
  • Further refinement may be needed to improve the accuracy of shunt ratio quantification.
  • The device offers a promising alternative for clinical decision-making in pediatric congenital heart disease management.